Re: A comparison of the recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from the major guidelines: Impact on thromboprophylaxis rates of implementing Royal College of Obstetricians and Gynaecologists' guidance for reducing the risk of ante- and postnatal venous thromboembolism.
King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Hannah E
HE
Omunakwe
King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Lara N
LN
Roberts
King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.|Institute of Pharmaceutical Science, King's College London, London, UK.
Jig P
JP
Patel
Women's Health, King's College Hospital NHS Foundation Trust, London, UK.
Devi
D
Subramanian
King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Roopen
R
Arya
D000925:Anticoagulants; D002585:Cesarean Section; D005260:Female; D006495:Heparin, Low-Molecular-Weight; D006801:Humans; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D054556:Venous Thromboembolism
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight